Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Risk of Lung Cancer”

326 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 326 results

Not applicableLooking for participantsNCT07358715
What this trial is testing

Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals

Who this might be right for
Lung CancerLung NeoplasmsEarly Lung Cancer Detection+2 more
National University Hospital, Singapore 140
Not applicableStudy completedNCT04922697
What this trial is testing

Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study

Who this might be right for
Lung Carcinoma
Fred Hutchinson Cancer Center 25
Early research (Phase 1)Study completedNCT01471067
What this trial is testing

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma+2 more
M.D. Anderson Cancer Center 33
Post-approval studies (Phase 4)WithdrawnNCT03988231
What this trial is testing

Enoxaparin Versus Placebo for Venous Thromboembolism Prevention in Low Risk Cancer Patients After Surgical Procedures: a Randomized, Double Blind, Placebo Controlled Clinical Trial Pilot Study

Who this might be right for
Venous ThromboembolismBleeding as Surgical Complication (Treatment)Deep Venous Thrombosis+1 more
University of Utah
Not applicableStudy completedNCT02558101
What this trial is testing

Lung Screen Uptake Trial

Who this might be right for
Lung Cancer
University College, London 1,997
Not applicableWithdrawnNCT01809730
What this trial is testing

Pilot Study: Cardiovascular Events in High Risk Orthopedic Surgical Patients

Who this might be right for
Coronary Artery DiseaseCerebral Vascular DiseasePeripheral Artery Disease+8 more
NYU Langone Health
Large-scale testing (Phase 3)Temporarily pausedNCT00211952
What this trial is testing

Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

Who this might be right for
Non-Small Cell Lung Cancer
Medical University of Gdansk 542
Testing effectiveness (Phase 2)Looking for participantsNCT06924398
What this trial is testing

Postoperative EGFR-TKI Therapy forContralateral Pulmonary Nodules in Patients With EGFR-Mutant NSCLC（ARMOR2501）

Who this might be right for
Lung Cancer (NSCLC)
Sun Yat-sen University 32
Not applicableLooking for participantsNCT05198154
What this trial is testing

CtDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC

Who this might be right for
Advanced Lung Non-Small Cell Carcinoma
Fang Wu 100
Not applicableUnknownNCT01106937
What this trial is testing

Factor XIII and Pulmonary Embolism in Neurosurgical Patients

Who this might be right for
Brain TumorVascular LesionFactor XIII Deficiency+1 more
Ludwig-Maximilians - University of Munich 130
Not applicableNot Yet RecruitingNCT06473870
What this trial is testing

Understanding Lung Cancer Related Risk Factors and Their Impact

Who this might be right for
Lung Cancer Screening
Biobizkaia Health Research Institute 6,160
Not applicableUnknownNCT02898441
What this trial is testing

Early Stage Lung Cancer Screening With Low-dose Computed Tomographic

Who this might be right for
Lung Cancer
Shanghai Chest Hospital 6,000
Not applicableStudy completedNCT05937399
What this trial is testing

Project PLUS Lung Cancer Screening Promotion

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Ended earlyNCT00404703
What this trial is testing

Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 37
Not applicableStudy completedNCT03862001
What this trial is testing

Lung Cancer Screening: A Multilevel Intervention

Who this might be right for
Lung Cancer
University of California, San Francisco 66
Not applicableWithdrawnNCT01602432
What this trial is testing

Implementing a Tool to Identify Risk for Venous Thromboembolism in Cancer Patients

Who this might be right for
Venous ThromboembolismDeep-Vein ThrombosisPulmonary Embolism+1 more
Ottawa Hospital Research Institute
Not applicableLooking for participantsNCT06962670
What this trial is testing

Predicting Cancer Risk With Digital and Molecular Markers

Who this might be right for
Breast CancerLung CancerColorectal Cancer+1 more
University of Erlangen-Nürnberg Medical School 1,250
Not applicableStudy completedNCT03048760
What this trial is testing

Magnetic Resonance Imaging (MRI) for the Delineation of Organs At Risk (OAR) and Target Volumes in Lung Cancer Patients

Who this might be right for
Lung Cancer
The Christie NHS Foundation Trust 30
Not applicableActive Not RecruitingNCT02611570
What this trial is testing

LDCT Screening in Non-smokers in Taiwan

Who this might be right for
Lung Cancer
Academia Sinica, Taiwan 12,000
Not applicableLooking for participantsNCT05898594
What this trial is testing

Lung Cancer Screening in High-risk Black Individuals

Who this might be right for
Lung CancerLung Carcinoma
Massachusetts General Hospital 900
Load More Results